Advances & Updates

First PNOC clinical trial open in Israel and Australia!

PNOC's Global Reach Expands,

PNOC is excited to announce that after many months of effort, communication, regulatory and ethical board review, our centers in Australia and Israel have officially opened their first PNOC study to accrual! They have opened PNOC019, “A Randomized, Double-Blinded, Pilot Trial of Neoadjuvant Checkpoint Inhibition followed by Combination Adjuvant Checkpoint Inhibition in Children and Young Adults with Recurrent or Progressive High Grade Glioma (HGG).”

PNOC is committed to bringing our clinical trials and options for treatment to all corners of the world, and our partners in these countries are working to open more trials for more patients.